Does economisation of medicine transfer into benefits for patients?

Thematic Poster
Chairs: C. Roberts (Leytonstone, United Kingdom), M. Urban (WIEN, Austria), J. Lopez-Campos Bodineau (Sevilla, Spain), D. Doberer (Wien, Austria)
Late Breaking Abstract - Financial burden of ILD – a claims data based study
L. Schwarzkopf (Neuherberg, Germany)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
The cost burden of COPD in France: A retrospective analysis of an administrative primary care database
W. Meeraus (Uxbridge, United Kingdom)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Cost impact of time to initiation of triple therapy in COPD patients in Japan: A retrospective analysis of healthcare claims data
A. Ismaila (Cary, United States of America)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Cost-effectiveness of umeclidinium bromide 62.5µg or alternative LAMA plus ICS/LABA in COPD
M. Driessen (Brentford, United Kingdom)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Cost effectiveness of umeclidinium bromide 62.5µg plus ICS/LABA versus ICS/LABA in COPD
M. Driessen (Brentford, United Kingdom)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Single inhaler triple therapy in patients with advanced COPD: healthcare resource utilisation and cost data from the FULFIL study
A. Ismaila (Cary, United States of America)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Cost-effectiveness of fixed-dose combinations therapies for COPD in Spain
L. leandro (Spain)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Cost-effectiveness of tiotropium versus glycopyrronium in moderate to very severe COPD in France
L. Luciani (Paris, France)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Cost-effectiveness analysis of afatinib vs gefitinib in EGFR-Mutated population with advanced non-small-cell lung cancer
L. Luciani (Paris, France)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Cost-effectiveness of afatinib versus erlotinib for the treatment of squamous non-small cell lung cancer in france after a first-line platinum based therapy
L. Luciani (Paris, France)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
IMPACT OF COMORBIDITY ON DIRECT MEDICAL COSTS OF COMMUNITY-ACQUIRED PNEUMONIA (CAP)
A. Demchuk (Vinnytsia, Ukraine)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Cost Effectiveness Of Bronchial Thermoplasty For Treatment Of Severe Asthma Patients In Scotland
W. Lee (Glasgow, United Kingdom)
Congress or journal article abstract
Congress or journal article abstract
Cost effectiveness of bronchial thermoplasty for treatment of severe asthma patients in spain
L. Puente Maestu (Madrid, Spain)
Congress or journal article abstract
Congress or journal article abstract
Can correct inhalation technique programs reduce costs due to hospitalization of patients with obstructive pulmonary diseases?
Z. Ivanova (Pleven, Bulgaria)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Economic burden of asthma among patients visiting a private hospital in south India
S. Aneeshkumar (KOLLAM (KERALA), India)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Non fulfillment adherence in a Czech outpatient department serving COPD and astma patients in one year
P. Turcáni (Brno, Czech Republic)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster